SHIV/HIV Env-antibody coevolution as a molecular guide to V3 glycan targeted vaccine design
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
University of Pennsylvania
Start Date
June 1, 2022
End Date
March 31, 2026
Administered By
Duke Human Vaccine Institute
Awarded By
University of Pennsylvania
Start Date
June 1, 2022
End Date
March 31, 2026